Ownership

Matt Abernethy - Chief Financial Officer at Neurocrine Biosciences Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Stock Symbol: NBIX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Matt Abernethy - trading volume in the past year for Neurocrine Biosciences Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-49.9K	100%	$141.65	-$7.07M
Net	-49.9K	-100%		-$7.07M

Holdings reported by Matt Abernethy for Neurocrine Biosciences Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	31.5K	$4.74M	$150.38	Aug 13, 2024	Direct
Restricted Stock Unit	8.97K	$388K	$43.24	Feb 13, 2024	Direct	Common Stock
Non-Qualified Stock Option	0	$0	$73.60	Aug 13, 2024	Direct	Common Stock
Stock Option	45.1K			Feb 13, 2024	Direct	Common Stock

Transactions reported by Matt Abernethy for Neurocrine Biosciences Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.